Coherus BioSciences Inc (CHRS) — Net Asset Quality Index
Coherus BioSciences Inc (CHRS) has a Net Asset Quality Index of 31.8% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $191.18 Million minus total liabilities of $130.34 Million yields net assets of $60.84 Million. A higher index indicates a stronger, lower-leverage balance sheet. Read CHRS liabilities breakdown for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Coherus BioSciences Inc Net Asset Quality Index Over Time (2012–2025)
This chart shows how Coherus BioSciences Inc's Net Asset Quality Index has evolved across 14 annual periods from 2012 to 2025. As of June 2026, the index stands at 31.8%, representing net assets of $60.84 Million against total assets of $191.18 Million USD. For live market cap and overall valuation, see market cap of Coherus BioSciences Inc.
Annual Net Asset Quality Index for Coherus BioSciences Inc (2012–2025)
The table below presents the year-by-year Net Asset Quality Index for Coherus BioSciences Inc from 2012 to 2025, covering 14 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Check CHRS capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 23.6% | $61.01 Million | $258.34 Million | $197.33 Million | ▲ +53.0 pp |
| 2024 | -29.4% | $-131.99 Million | $448.53 Million | $580.52 Million | ▲ +1.3 pp |
| 2023 | -30.7% | $-193.43 Million | $629.60 Million | $823.03 Million | ▼ -2.1 pp |
| 2022 | -28.6% | $-137.42 Million | $480.85 Million | $618.26 Million | ▼ -43.0 pp |
| 2021 | 14.4% | $97.73 Million | $679.33 Million | $581.61 Million | ▼ -19.0 pp |
| 2020 | 33.4% | $280.97 Million | $841.65 Million | $560.67 Million | ▲ +7.7 pp |
| 2019 | 25.7% | $105.21 Million | $408.93 Million | $303.71 Million | ▲ +64.5 pp |
| 2018 | -38.8% | $-38.59 Million | $99.47 Million | $138.06 Million | ▼ -57.6 pp |
| 2017 | 18.8% | $30.54 Million | $162.61 Million | $132.08 Million | ▲ +7.9 pp |
| 2016 | 10.8% | $19.35 Million | $178.49 Million | $159.13 Million | ▲ +14.1 pp |
| 2015 | -3.3% | $-6.93 Million | $212.38 Million | $219.31 Million | ▼ -38.9 pp |
| 2014 | 35.7% | $66.76 Million | $187.22 Million | $120.46 Million | ▲ +125.0 pp |
| 2013 | -89.3% | $-42.38 Million | $47.45 Million | $89.83 Million | ▼ -124.0 pp |
| 2012 | 34.6% | $9.19 Million | $26.53 Million | $17.34 Million | — |